Acceso Abierto

Original antigenic sin: A comprehensive review

Título de la revista
Vatti A.
Monsalve Carmona, Diana Marcela
Pacheco Y.
Chang C.
Anaya, Juan-Manuel
Gershwin M.E.



ISSN de la revista
Título del volumen
Academic Press

Buscar en:

Métricas alternativas

The concept of “original antigenic sin” was first proposed by Thomas Francis, Jr. in 1960. This phenomenon has the potential to rewrite what we understand about how the immune system responds to infections and its mechanistic implications on how vaccines should be designed. Antigenic sin has been demonstrated to occur in several infectious diseases in both animals and humans, including human influenza infection and dengue fever. The basis of “original antigenic sin” requires immunological memory, and our immune system ability to autocorrect. In the context of viral infections, it is expected that if we are exposed to a native strain of a pathogen, we should be able to mount a secondary immune response on subsequent exposure to the same pathogen. “Original antigenic sin” will not contradict this well-established immunological process, as long as the subsequent infectious antigen is identical to the original one. But “original antigenic sin” implies that when the epitope varies slightly, then the immune system relies on memory of the earlier infection, rather than mount another primary or secondary response to the new epitope which would allow faster and stronger responses. The result is that the immunological response may be inadequate against the new strain, because the immune system does not adapt and instead relies on its memory to mount a response. In the case of vaccines, if we only immunize to a single strain or epitope, and if that strain/epitope changes over time, then the immune system is unable to mount an accurate secondary response. In addition, depending of the first viral exposure the secondary immune response can result in an antibody-dependent enhancement of the disease or at the opposite, it could induce anergy. Both of them triggering loss of pathogen control and inducing aberrant clinical consequences. © 2017 Elsevier Ltd
Palabras clave
Antigen , humoral , immunological , Epitope , Vaccine , Antigen , Antibody dependent enhancement , Chlamydia trachomatis , Dengue virus , Enterovirus , Human bocavirus , Human immunodeficiency virus , Humoral immunity , Immune response , Influenza virus , Leptospirosis , Nonhuman , Plasmodium , Priority journal , Review , Secondary immune response , Zika virus , Animal , Biological model , Human , Immunological memory , Immunological tolerance , Immunology , Infection , Animals , Antigens , Humans , Immune tolerance , Immunity , Immunodominant epitopes , Immunologic memory , Infection , Models , Vaccines , Antibody-dependent enhancement , Bocavirus , Dengue , Influenza , Memory immune response , Vaccination , Zika virus
Buscar en: